Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare

Chinese Journal of Integrative Medicine

Volumn 21, Issue 2, 2015, Pages 83-89

  Chan, Kelvin ^a,b  

^a WESTERN SYDNEY UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

adverse effects; beneficial co treatment; Chinese medicines and pharmaceutical drugs interactions; future directions; herb drug interaction; possible mechanisms

Indexed keywords

ARTICLE; CHINESE MEDICINE; CLINICAL FEATURE; CONSULTATION; DATA BASE; DRUG INTERACTION; EMERGENCY CARE; HEALTH STATUS; HERBAL MEDICINE; HUMAN; INTEGRATIVE MEDICINE; INTERNET; MEDICAL CARE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; SELF CARE; WELLBEING; HEALTH CARE DELIVERY; METABOLISM;

DRUG; HERBACEOUS AGENT;

DELIVERY OF HEALTH CARE; DRUG INTERACTIONS; DRUGS, CHINESE HERBAL; HUMANS; INTEGRATIVE MEDICINE; PHARMACEUTICAL PREPARATIONS;

EID: 84925539245     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-014-1794-y     Document Type: Article

References (19)

1. Helmut Kaiser Consultancy HKC22. Traditional Chinese medicine: with overview worldwide market, development, products and companies. Available at: www.hkc22.com.
2. Chan K. Chinese medicinal materials and their interface with Western medical concepts. J Ethnopharmacol 2005;96:1–18.
3. Dobos G, Tao I. The model of Western integrative medicine: The role of Chinese medicine. Chin J Integr Med 2011;17:11–20.
4. Lu AP, Ding XR, Chen KJ. Current situation and progress in integrative medicine in China. Chin J Integr Med 2008;14:234–240.
5. Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134–138.
6. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 2009;69:1777–1798.
7. Bush TM, Rayburn KS, Holloway SW, Sanchez-Yamamoto DS, Allen BL, Lam T, et al. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. Altern Therap Health Med 2007;13:30–35.
8. Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Survivorship 2010. DOI: 10.1007/s11764-010-0153-7.
9. Chan K, Cheung L, eds. Interactions between Chinese herbal medicinal products and orthodox drugs. New York, Oxford & Philadelphia; Taylor & Francis Group; 2000:176.
10. Jiang, M, Lu C, Zhang C, Yang J, Tan Y, Lu A, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmcol 2012;140:634–642.
11. Chan K, Poon J, Poon S, Jiang M, Lu A. An overview on evidence-based medicine and medical informatics in traditional Chinese medicine practice. In: Poon J, Poon S, eds. Data analysis for traditional Chinese medicine research. Switzerland: Springer International Publishing Ltd., 2014:227–248.
12. Williamson EM, Lorenc A, Booker A, Robinson N. The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China. J Ethnopharmacol 2013;49:453–462.
13. Mills S. Herbal medicines: research strategies. In: Fundamentals of complementary and alternative medicine. London International Edition; 1996:394–407.
14. National Center for Complementary and Alternative Medicine (NCCAM): What research will NCCAM fund? Available at: http://nccam.nih.gov/grants/whatnccamfunds.
15. GPTCM. Good Practice in Traditional Chinese Medicine Research Consortium supported by EU-FP7 fund. J Ethnopharmacol 2012;140:455–644.
16. National Health and Medical Research Council, Complementary medicine gets a boost. Available at: https://www.nhmrc.gov.au/grants/outcomes-fundingrounds/historical-information-capacity-building-grants/complementary-and-alt.
17. Tsang I, Huang S, Koelhler B. Integration of Chinese medicine and Western medicine in clinical practice (patient care): past, present and a proposed model for the future. Chin J Integr Med 2013;19:83–85.
18. Alsanand S, Williumson EM, Howard RL Cancer patient at risk of herbal/food supplement-drug interactions: a systematic review. Phytother Res 2014; DOI: 10.1002/ptr.5213.
19. Global Alliance for Chronic diseases. Released on 26th July 2013 by Members of Global Alliance for Chronic Diseases to fund landmark research initiative to reduce impact of diabetes. Available at: http://www.diabetes.co.uk/globaldiabetes/diabetes-in-china.html.